UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Respiratory tract infections and gut microbiome modifications: A systematic review

PloS one, 2022-01, Vol.17 (1), p.e0262057-e0262057

2022

Volltextzugriff (PDF)

Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity

PloS one, 2021-04, Vol.16 (4), p.e0249944-e0249944

2021

Volltextzugriff (PDF)

The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease

PloS one, 2019-10, Vol.14 (10), p.e0223952-e0223952

2019

Volltextzugriff (PDF)

Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (2), p.192-202

2018

Volltextzugriff (PDF)

Rhinovirus infections change DNA methylation and mRNA expression in children with asthma

PloS one, 2018-11, Vol.13 (11), p.e0205275-e0205275

2018

Volltextzugriff (PDF)

Deficient pulmonary IFN-β expression in COPD patients

PloS one, 2019-06, Vol.14 (6), p.e0217803-e0217803

2019

Volltextzugriff (PDF)

Moraxella-dominated pediatric nasopharyngeal microbiota associate with upper respiratory infection and sinusitis

PloS one, 2021-12, Vol.16 (12), p.e0261179

2021

Volltextzugriff (PDF)

A high-throughput cigarette smoke-treated bronchosphere model for disease-relevant phenotypic compound screening

PloS one, 2023-06, Vol.18 (6), p.e0287809-e0287809

2023

Volltextzugriff (PDF)

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients

PloS one, 2019-09, Vol.14 (9), p.e0222449

2019

Volltextzugriff (PDF)

Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD

PloS one, 2022-12, Vol.17 (12), p.e0277357-e0277357

2022

Volltextzugriff (PDF)

Metabolomic profiling of microbial disease etiology in community-acquired pneumonia

PloS one, 2021-06, Vol.16 (6), p.e0252378

2021

Volltextzugriff (PDF)

The Toll-Like Receptor 5 agonist flagellin prevents Non-typeable Haemophilus influenzae-induced infection in cigarette smoke-exposed mice

PloS one, 2021-03, Vol.16 (3), p.e0236216

2021

Volltextzugriff (PDF)

Evaluation of the anti-inflammatory effects of synthesised tanshinone I and isotanshinone I analogues in zebrafish

PloS one, 2020-10, Vol.15 (10), p.e0240231-e0240231

2020

Volltextzugriff (PDF)

Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction

PloS one, 2017-10, Vol.12 (10), p.e0184566-e0184566

2017

Volltextzugriff (PDF)

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality

PloS one, 2017-03, Vol.12 (3), p.e0173830-e0173830

2017

Volltextzugriff (PDF)

Evidence of superficial knowledge regarding antibiotics and their use: Results of two cross-sectional surveys in an urban informal settlement in Kenya

PloS one, 2017-10, Vol.12 (10), p.e0185827-e0185827

2017

Volltextzugriff (PDF)

In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients

PloS one, 2019-01, Vol.14 (1), p.e0210188-e0210188

2019

Volltextzugriff (PDF)

A host gene expression approach for identifying triggers of asthma exacerbations

PloS one, 2019-04, Vol.14 (4), p.e0214871-e0214871

2019

Volltextzugriff (PDF)

Variations of the lung microbiome and immune response in mechanically ventilated surgical patients

PloS one, 2018-10, Vol.13 (10), p.e0205788

2018

Volltextzugriff (PDF)

Chronic obstructive pulmonary disease candidate gene prioritization based on metabolic networks and functional information

PloS one, 2017-09, Vol.12 (9), p.e0184299-e0184299

2017

Volltextzugriff (PDF)

Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care—Associated Pneumonia: A UK Cohort Study

Clinical infectious diseases, 2011-07, Vol.53 (2), p.107-113

2011

Volltextzugriff (PDF)

Is community-acquired pneumonia an independent risk factor for cardiovascular disease?

The European respiratory journal, 2012-01, Vol.39 (1), p.187-196

2012

Volltextzugriff (PDF)

Is community-acquired pneumonia an independent risk factor for cardiovascular disease?

The European respiratory journal, 2012-01, Vol.39 (1), p.187-196

2012

Volltextzugriff (PDF)

Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia

Thorax, 2009-07, Vol.64 (7), p.592-597

2009

Volltextzugriff (PDF)

1 – 25 von 275

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(232)

Publikationsform

Sprache

Englisch
(275)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Humans
(137)
Life Sciences & Biomedicine
(133)
Female
(68)
Male
(67)
Middle Aged
(58)
Respiratory System
(57)
Aged
(51)
Chronic Obstructive Pulmonary Disease
(43)
Adult
(34)
Inflammation
(33)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Infections
(30)
Infectious Diseases
(30)
General & Internal Medicine
(29)
Pneumonia
(28)
Risk Factors
(28)
Animals
(27)
Immunology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Respiratory tract infections and gut microbiome modifications: A systematic review

Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity

The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease

Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease

Rhinovirus infections change DNA methylation and mRNA expression in children with asthma

Deficient pulmonary IFN-β expression in COPD patients

Moraxella-dominated pediatric nasopharyngeal microbiota associate with upper respiratory infection and sinusitis

A high-throughput cigarette smoke-treated bronchosphere model for disease-relevant phenotypic compound screening

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients

Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD

Metabolomic profiling of microbial disease etiology in community-acquired pneumonia

The Toll-Like Receptor 5 agonist flagellin prevents Non-typeable Haemophilus influenzae-induced infection in cigarette smoke-exposed mice

Evaluation of the anti-inflammatory effects of synthesised tanshinone I and isotanshinone I analogues in zebrafish

Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality

Evidence of superficial knowledge regarding antibiotics and their use: Results of two cross-sectional surveys in an urban informal settlement in Kenya

In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients

A host gene expression approach for identifying triggers of asthma exacerbations

Rhinovirus infection results in stronger and more persistent genomic dysregulation: Evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescence

Variations of the lung microbiome and immune response in mechanically ventilated surgical patients

Chronic obstructive pulmonary disease candidate gene prioritization based on metabolic networks and functional information

Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care—Associated Pneumonia: A UK Cohort Study

Is community-acquired pneumonia an independent risk factor for cardiovascular disease?

Is community-acquired pneumonia an independent risk factor for cardiovascular disease?

Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia

Suchergebnisse filtern